Health ❯Healthcare ❯Medical Research ❯Cancer Research

Pancreatic Cancer

KRAS-Targeted Vaccine Shows Robust Immune Response, Longer-Than-Expected Survival in Pancreatic and Colorectal Cancer Trial

Researchers plan larger studies of a multivalent version to confirm benefit.

Off-The-Shelf KRAS Vaccine Yields Robust T-Cell Responses and Survival Benefit